Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer.
52W Range
32ndpctl
Volume
3.61×avg
Market Cap
45.84MUSD
P/E Ratio
-1.3TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Werewolf Therapeutics, Inc.
HOWLNASDAQ Global Select·USD·Closed
Werewolf Therapeutics, Inc.
HOWLNASDAQ·USD·Closed
$0.94
−2.83%
$0.94
−$0.03 (2.83%)
52W Range
32ndpctl
Volume
3.61×avg
Mkt Cap
45.84MUSD
P/E
-1.3TTM
Div Yield
–ann
HOWL: Werewolf Therapeutics, Inc. Stock Analysis | finqOS
